|
|
|
|
Biotechnology industry growing, despite constraints
The South African biotechnology industry is still developing and this should be seen as an advantage, intellectual property law firm Adams & Adams biotechnology expert and candidate attorney Dr William Modisakeng tells...
|
|
|
U.S. Farmers Prefer Biotech Varieties of Corn, Cotton, Soybeans
Biotechnology Industry Organization Herbicide-tolerant and insect-resistant traits make biotech crops attractive to U.S.farmers WASHINGTON, D.C. (Wednesday, July 01, 2009) - American farmers have adopted genetically...
|
|
|
Biotechnology, trade, keys for wheat
The adoption of biotechnology, export expansion, and supplier reliability are crucial components to further bolster the U.S.wheat industry a $16.5 billion economic powerhouse in 2008. Bringing biotechnology into the wheat...
|
|
|
Johnson & Johnson Completes Initial Tender Offer For Cougar Biotech - Quick Facts
AM ET RELATED NEWS TOP MARKET NEWS (RTTNews) - Johnson & Johnson (JNJ: News ) announced that the initial offering period of its tender offer for all outstanding shares of common stock of Cougar Biotechnology Inc.(CGRB: News )...
|
|
|
AGRICULTURE: Biotechnology: Africa Must Not Be Left Behind
By Wambi Michael KAMPALA, Jul 3 (IPS) - Africa must embrace agricultural biotechnology or risk being excluded from a major technological revolution that has had increased food production in the Europe, North America and Asia.
|
|
|
Future of biotech wheat lies with growers, pr
As the wheat industry continues its long progress toward the development of a commercially viable biotech wheat seed, it's important to recognize where the industry has been, as well as where it hopes to end up.Wheat Associates Vice...
|
|
|
Future of biotech wheat lies with growers, providers
As the wheat industry continues its long progress toward the development of a commercially viable biotech wheat seed, it's important to recognize where the industry has been, as well as where it hopes to end up.Wheat Associates Vice...
|
|
|
U. Iowa sues drugmaker alleging patent infringement
Source: The Daily Iowan, U.Iowa The University of Iowa is involved in a legal dispute with the makers of Humira, for allegedly intentionally violating two UI patented medical tools. The same company Abbott Labs lost a patent lawsuit...
|
|
|
UI sues drugmaker alleging patent infringement
The UI is involved in a legal dispute with the makers of Humira, for allegedly intentionally violating two UI patented medical tools.The same company Abbott Labs lost a patent lawsuit Monday, when an eastern Texas federal jury found...
|
|
|
UPDATE 1-J&J says 84.4 pct of Cougar shares tendered
, 11:31 AM EDT * Says about 17.7 mln shares tendered * Says subsequent offering period ends on July 9 * Gets commitments to tender 2 mln more shares July 3 (Reuters) - Johnson & Johnson said about 84.4 percent of the outstanding shares...
|
|
|
UPDATE 1-J&J says 84.4 pct of Cougar shares tendered
* Says about 17.7 mln shares tendered * Says subsequent offering period ends on July 9 * Gets commitments to tender 2 mln more shares July 3 (Reuters) - Johnson & Johnson said about 84.4 percent of the outstanding shares of Cougar ...
|
|
|
UPDATE 1-J&J says 84.4 pct of Cougar shares tendered
* Says subsequent offering period ends on July 9 * Gets commitments to tender 2 mln more shares July 3 (Reuters) - Johnson & Johnson said about 84.4 percent of the outstanding shares of Cougar Biotechnology Inc were tendered...
|
|
|
Oncolytics Biotech(R) Inc. Completes Patient Enrolment in U.K. Combination REOLYSIN(R) and Paclitaxel/Carbopla
CALGARY, July 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.announced today that patient enrolment has been completed in the Phase II component of a Phase I/II U.K. trial of REOLYSIN combined with paclitaxel/carboplatin for...
|
|
|
Oncolytics Biotech(R) Inc. Completes Patient Enrolment in U.K. Combination REOLYSIN(R) and Paclitaxel/Carbopla
CALGARY, July 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.announced today that patient enrolment has been completed in the Phase II component of a Phase I/II U.K. trial of REOLYSIN combined with paclitaxel/carboplatin for...
|
|
|
Big push underway for generic biotech drugs
Biotech drugs were largely excluded from the 1984 landmark law that permitted the sale of generic medicines.But a push is underway to correct that omission a move supporters say could boost access to vital treatments for cancer,...
|
|
|
Drug firms' suit against MIT unusual
Biotech companies fight with each other over the commercial rights to ideas and technology all the time.Patent lawsuits are as much a part of the business as lab work and clinical trials. But those companies rarely go to court...
|
|
|
Is IBB the Best Biotech ETF?
Healthcare has dominated the headlines in recent weeks, as President Obama presents his new proposals and the industry recovers from a position where it was perhaps oversold.Where, in this mix, are ETFs the most helpful? iShares Nasdaq ...
|
|
|
Is IBB the Best Biotech ETF
Healthcare has dominated the headlines in recent weeks, as President Obama presents his new proposals and the industry recovers from a position where it was perhaps oversold.Where, in this mix, are ETFs the most helpful? iShares Nasdaq ...
|
|
|
MorphoSys AG (DE) - MorphoSys Announces Clinical Milestone in Therapeutic Antibody Program
Seventh HuCAL Antibody to Enter Clinical Trials MARTINSREID, Germany June 29, 2009--MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced today that it will receive a milestone payment from Centocor Ortho Biotech Inc....
|
|
|
MorphoSys Announces Clinical Milestone in Therapeutic Antibody Program
Seventh HuCAL Antibody to Enter Clinical Trials Martinsried/Munich, Germany, June 29th, 2009 - MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced today that it will receive a milestone payment from Centocor Ortho Biotech...
|
|
|
Oncolytics Biotech Inc. Completes Patient Enrolment in U.K. Combination Reolysin and Paclitaxel/Carboplatin He
CALGARY, July 2 /PRNewswire-FirstCall/ -- Oncolytics Biotech Inc.(TSX: ONC, NASDAQ: ONCY) announced today that patient enrolment has been completed in the Phase II component of a Phase I/II U.K. trial of REOLYSIN combined with...
|
|
|
U.S. farmers prefer biotech varieties of corn
American farmers have adopted genetically engineered (GE) crops widely since their introduction in 1996, especially corn, cotton and soybean varieties, according to a new USDA report.USDA's Economic Research Service (ERS) report, Adoption...
|
|
|
USDA Releases 'Adoption of Genetically Engineered Crops in the U.S.'
Source: BIO news release American farmers have adopted genetically engineered (GE) crops widely since their introduction in 1996, especially corn, cotton and soybean varieties, according to a new USDA report.USDA's Economic Research...
|
|
|
Oncolytics Biotech(R) Inc. Completes Patient Enrolment in U.K. Combination REOLYSIN(R) and Paclitaxel/Carbopla
CALGARY , July 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.(TSX: ONC, NASDAQ: ONCY) announced today that patient enrolment has been completed in the Phase II component of a Phase I/II U.K. trial of REOLYSIN combined with...
|
|
|
Oncolytics Biotech(R) Inc. Completes Patient Enrolment in U.K. Combination REOLYSIN(R) and Paclitaxel/Carbopla
CALGARY, July 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.(TSX: ONC, NASDAQ: ONCY) announced today that patient enrolment has been completed in the Phase II component of a Phase I/II U.K. trial of REOLYSIN combined with...
|
